NEWPARK SURGERY
TALBOT GREEN GROUP PRACTICE, HEOL-Y-GYFRAITH, TALBOT GREEN, PONTYCLUN
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 17 | 20 | 85.0% | |
| HF 4 | 2011 | 26 | 37 | 70.3% | |
| HF 4 | 2012 | 28 | 38 | 73.7% | |
| HF 4 | 2013 | 29 | 36 | 80.6% | |
| HF004W | 2014 | 36 | 38 | 94.7% | |
| HF004 | 2015 | 36 | 40 | 90.0% |
